openPR Logo
Press release

Fabry Disease Market Intelligence Report Offers Growth Prospects

03-30-2017 02:32 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Fabry Disease Market Intelligence Report Offers Growth

Fabry diseaseis also known as Anderson-Fabry disease and alpha-galactosidase A deficiency. It is a rare genetic disorder of lipid metabolism resulting from the deficient activity of the alpha-galactosidase A (a-Gal A) enzyme. The deficiency of the enzyme is caused by the alterations in the genes that instructs the cells to make alpha-galactosidase A (a-Gal A) enzyme. Fabry disease is known to cause variety of systemic symptoms and complications, one of them being metabolic disorders. The metabolism of sphingolipids is minimized, in fabry disease which results in the multiple organ failure and death. Owing to the deficiency of alpha galactosidase A enzyme, glycolipid called Gb3 accumulates in the blood vessels and other organs and thus results in formation of blockage or clots that leads to malfunctioning of the system.

Fabry Disease Market: Drivers and Restraints

The major drivers that drive the fabry disease market growth are extensive R&D activities, adoption of advanced technologies in the research practices. Due to hereditary nature and severity of the disease, complications in physiological systems, such as cardiac system, urinary system and others are expected to increase the demand for trustworthy treatment. Extensive R&D practices is one of the valuable drivers of the market. Due to this, various therapeutic products, such as, PRX-102, JR-051, NP-003, GC-1119 and others, are under pipeline studies. However, rare incidence rate (1 in 40,000), lack of awareness about advancements in genetic sciences, technological limitations in certain region of the world are some of the restraining factors that may affect the growth of the fabry disease market.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1365

Fabry Disease Market: Overview

The enzyme replacement therapy is designed to provide enzyme to the patients suffering from enzyme deficiency. It was found that this treatment was not a complete cure though it improved the metabolism. Enzyme replacement therapy is the most expensive and unaffordable treatment among the treatments for fabry disease, hence the market for enzyme replacement therapy is expected to register moderate growth in overall fabry disease market. The analgesics, anticonvulsants and NSAIDs are generally known for the treatment of pain and other symptoms associated with fabry disease hence, contributing majorly to the market.

Fabry Disease Market: Regional Overview

Geographically, the global fabry disease market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, APAC, Japan, Middle East and Africa.North America is estimated to be the most lucrative region owing to the affordability of the treatment followed by Europe. The rare incidences in APAC and MEA countries are expected to limit the growth of fabry disease market in these regions.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1365

Fabry Disease Market: Key Players

The major players operating in this market and involved in development of new medications include Sanofi-Aventis LLC, iBio, Inc., GlaxoSmithKline plc, Genzyme Corporation, and Neuraltus Pharmaceuticals, Inc. Some of the existing key players in the global fabry disease market are Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Amgen Inc., Teva pharmaceutical Industries Ltd., Pfizer Inc., Takeda Pharmaceutical Co. Ltd.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Press: press@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fabry Disease Market Intelligence Report Offers Growth Prospects here

News-ID: 486446 • Views:

More Releases from Future Market Insights

Beverage Cartoners Market Poised to Reach USD 1.1 Billion by 2033 as Innovation and Personalization Drive Growth
Beverage Cartoners Market Poised to Reach USD 1.1 Billion by 2033 as Innovation …
The global beverage cartoners market is set for robust expansion, growing from USD 742.3 million in 2023 to USD 1.1 billion by 2033, reflecting a CAGR of 4.9% over the forecast period. The surge in demand is driven by the rise of ready-to-drink beverages, technological advancements in cartoning machinery, and consumer preference for personalized and visually appealing packaging. Consumer Preferences Fuel Personalized Packaging Personalized packaging has emerged as a key trend in
Screen Printing Mesh Market to Reach USD 1,154.3 Million by 2035 Driven by Technological Innovation and Expanding Industrial Applications
Screen Printing Mesh Market to Reach USD 1,154.3 Million by 2035 Driven by Techn …
The global screen printing mesh market is projected to experience steady growth, with an estimated value of USD 772.3 million in 2025, expected to reach USD 1,154.3 million by 2035, reflecting a CAGR of 4.1% over the forecast period. This expansion is being driven by rising demand across textiles, electronics, packaging, and advertising industries, coupled with technological advancements that enhance printing precision, durability, and efficiency. Market Dynamics and Growth Drivers The screen
Germany Digital Textile Printing Market Set for Robust Growth as Innovation and Sustainability Drive the Industry Forward
Germany Digital Textile Printing Market Set for Robust Growth as Innovation and …
The global digital textile printing market is entering a transformative phase, with projected market value expected to reach USD 3.0 billion in 2025 and USD 5.6 billion by 2035, registering a CAGR of 6.4%. Sales in 2024 were estimated at approximately USD 2.82 billion, reflecting a steady rise in adoption of digital printing technologies across the textile and apparel industry. The growth trajectory is fueled by a growing demand for
Germany	 Heavy Duty Bag and Sack Market to Reach at 3.9% by 2035 Driven by Innovation and Expanding Applications
Germany Heavy Duty Bag and Sack Market to Reach at 3.9% by 2035 Driven by Innov …
The global heavy duty bag and sack market is on a promising growth trajectory, estimated to be worth USD 14.8 billion in 2025 and projected to reach USD 22.1 billion by 2035, reflecting a CAGR of 4.1% over the forecast period. Heavy-duty bags and sacks have become an essential component for industries that demand reliable, high-strength packaging, including agriculture, food processing, construction, and logistics. The market's growth is fueled by

All 5 Releases


More Releases for Fabry

U.S. Fabry Disease Market Size Report 2034
On April 28, 2025, Exactitude Consultancy., Ltd. released a research report titled "U.S. Fabry Disease Market". This report covers the global U.S. Fabry Disease market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.
Top Factor Driving Fabry Disease Treatment Market Growth in 2025: Impact of Incr …
How Are the key drivers contributing to the expansion of the fabry disease treatment market? The rising prevalence of renal diseases is expected to drive the growth of the Fabry disease treatment market. Renal diseases are becoming more prevalent due to genetic factors, lifestyle choices, and environmental influences. Fabry disease, which causes kidney dysfunction, is increasing and requires timely intervention. According to the Australian Bureau of Statistics, kidney disease affected 246,200
Fabry Disease Market Trends Analysis 2030
Fabry disease is a rare X-linked lysosomal storage disorder. This patient has a deficiency in the enzyme alpha galactosidase, which progresses to organ failure. The development of fabry illnesses is mostly caused by abnormal accumulation of a certain fatty substance known as globotriaosylceramide. This aberrant buildup can be detected in the skin, eyes, heart, kidney, brain, gastrointestinal system, and central nervous system, among other body parts. Galactosidase Alpha (GLA) is a
Fabry Disease Market Pipeline 2019 Analysis and Developmental Stages
"Fabry Disease - Pipeline Insight, 2019” report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Fabry Disease development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental Stages: - Clinical - Non-clinical - Inactive: Discontinued
Fabry Disease - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Fabry Disease - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fabry Disease - Pipeline Review, H1 2017, provides an overview of the Fabry Disease (Genetic Disorders) pipeline landscape. Fabry disease is an inherited disorder. Fabry disease results from abnormal deposits of a particular fatty substance (called
Worldwide Fabry Disease Market Report 2016-2026
Fabry diseaseis also known as Anderson-Fabry disease and alpha-galactosidase A deficiency. It is a rare genetic disorder of lipid metabolism resulting from the deficient activity of the alpha-galactosidase A (a-Gal A) enzyme. The deficiency of the enzyme is caused by the alterations in the genes that instructs the cells to make alpha-galactosidase A (a-Gal A) enzyme. Fabry disease is known to cause variety of systemic symptoms and complications, one of